Jubilant Ingrevia Limited to Buy 40% of Zettaone for ₹189.2 Crore

Jubilant Ingrevia Limited has agreed to acquire a 40% strategic equity stake in Zettaone Technologies India Private Limited for approximately ₹189.2 crore, marking its entry into electronics design and manufacturing services. The cash transaction is planned in two tranches, with the first targeted by November 2026 and the second by September 2027.

What has Jubilant Ingrevia announced?

Jubilant Ingrevia Limited has entered into a binding term sheet to acquire the 40% stake in Zettaone Technologies India Private Limited. The Board approved the proposed acquisition on August 18, 2026, and the company said Zettaone would become its associate after completion of the transaction.

Jubilant Ingrevia will make the acquisition through Jubilant Advanced Electronics Limited, a wholly owned subsidiary created to pursue electronics and semiconductor opportunities. The company described the investment as part of its Pinnacle Growth Strategy and its planned entry into the Electronics Development and Manufacturing Services, or EDMS, space.

The full consideration of approximately ₹189.2 crore is to be paid in cash. The first tranche is expected to close by November 2026, while the second is scheduled by September 2027. Zettaone will continue to operate as a standalone entity until the transaction is completed.

Why is the Zettaone stake important for Jubilant Ingrevia?

The Zettaone stake gives Jubilant Ingrevia a foothold in an electronics and semiconductor-related services business alongside its existing operations in specialty chemicals, nutrition and health solutions, and chemical intermediates. Management has said the combination is intended to create an integrated platform by bringing together Jubilant Ingrevia's scale, customer relationships, operational capabilities and CDMO experience with Zettaone's engineering and manufacturing expertise.

Zettaone provides electronics design, research and development, prototyping, manufacturing, assembly and box-build services. Its offerings serve applications in aerospace, defence, semiconductor, automotive, medical and industrial sectors. These capabilities place the company within the broader electronics manufacturing value chain rather than only one end-market.

Jubilant Ingrevia's presentation said execution of the proposed deal was on track, with customer traction and several customer bids in the pipeline. The available disclosure does not provide the value, conversion status or expected timing of these bids. It does, however, identify customer engagement as part of the rationale for entering the segment.

How has the transaction been structured?

The transaction is being routed through Jubilant Advanced Electronics Limited, a wholly owned subsidiary of Jubilant Ingrevia. The Board approved the subsidiary's incorporation on October 1, 2026, with its registered location stated as Gurugram, Haryana.

Jubilant Ingrevia said the subsidiary would receive an initial cash subscription of up to ₹10 crore for 100% of its initial paid-up share capital. The disclosed structure involves subscription for up to 1 crore equity shares of face value ₹10 each. This ₹10 crore amount relates to the initial capitalisation of the acquisition vehicle and is separate from the approximately ₹189.2 crore consideration for the proposed 40% Zettaone stake.

Using a dedicated subsidiary provides a separate operating vehicle for the electronics and semiconductor initiative. The company has characterised the structure as a way to maintain strategic focus and operational flexibility while it pursues the Zettaone transaction.

What do Zettaone's financial figures show?

Zettaone reported turnover of ₹98.1 crore in FY26, compared with ₹79.1 crore in FY25 and ₹51.1 crore in FY24. The disclosed figures show that its turnover increased in each of the last two reported financial years.

The turnover trajectory provides context for Jubilant Ingrevia's decision to take a strategic minority position rather than acquire full ownership. But the available information does not disclose Zettaone's profitability, debt, order book, valuation methodology or revenue contribution expected for Jubilant Ingrevia after the associate relationship begins.

The proposed investment also comes as Indian companies seek to build capabilities connected with electronics manufacturing and semiconductors. In this case, Jubilant Ingrevia has identified EDMS as the entry route, using Zettaone's existing design-to-box-build service platform.

How does the deal affect investors and business operations?

For Jubilant Ingrevia investors, the announced transaction represents a diversification initiative into a new operating area. Since the stake is 40%, Zettaone is expected to be an associate following closure, rather than a wholly owned business of Jubilant Ingrevia. The financial impact will therefore depend on completion of both tranches and the subsequent performance of the associate.

The company has not disclosed a change to its existing segment structure, any quantified earnings impact, or a specific revenue target from the EDMS initiative. The direct near-term corporate action is the creation and capitalisation of Jubilant Advanced Electronics Limited, followed by the planned completion of the stake acquisition.

For Zettaone, the partnership is intended to combine its design, engineering and manufacturing operations with Jubilant Ingrevia's larger platform and CDMO capabilities. The stated scope covers electronics and semiconductor opportunities, while Zettaone's present service base also spans aerospace, defence, automotive, medical and industrial applications.

Conclusion

Jubilant Ingrevia's proposed ₹189.2 crore investment for a 40% interest in Zettaone is a defined move into electronics design and manufacturing services. The transaction links Jubilant Ingrevia's established chemical and CDMO platform with Zettaone's electronics design, prototyping, manufacturing, assembly and box-build capabilities, while preserving Zettaone as an associate rather than a controlled subsidiary.

The next disclosed milestones are the first transaction tranche by November 2026 and the second by September 2027. Investors will also watch for formal closure updates, details on the associate's financial contribution and any further disclosures on customer bids or operating plans for Jubilant Advanced Electronics Limited.